Savior Lifetec Corporation (4167.TWO)
TWD 17.65
(-9.95%)
TWD 17.65
(-9.95%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 30.03 Million TWD | 45.66% |
| 2022 | 20.61 Million TWD | 532.84% |
| 2021 | -4.76 Million TWD | -101.9% |
| 2020 | 250.94 Million TWD | 669.71% |
| 2019 | -44.04 Million TWD | 87.75% |
| 2018 | -359.54 Million TWD | -1714.27% |
| 2017 | 22.27 Million TWD | 110.72% |
| 2016 | -207.69 Million TWD | 57.94% |
| 2015 | -493.79 Million TWD | -38.79% |
| 2014 | -355.79 Million TWD | -55.57% |
| 2013 | -228.7 Million TWD | 49.5% |
| 2012 | -452.83 Million TWD | -93.06% |
| 2011 | -234.56 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 21.88 Million TWD | -69.2% |
| 2024 Q1 | 71.07 Million TWD | 60.94% |
| 2023 Q3 | -16.5 Million TWD | -428.1% |
| 2023 Q4 | 44.16 Million TWD | 367.64% |
| 2023 FY | 30.03 Million TWD | 45.66% |
| 2023 Q1 | -1.61 Million TWD | 96.35% |
| 2023 Q2 | 5.02 Million TWD | 412.17% |
| 2022 FY | 20.61 Million TWD | 532.84% |
| 2022 Q4 | -44.08 Million TWD | -133.23% |
| 2022 Q2 | -6.02 Million TWD | 89.72% |
| 2022 Q3 | 132.66 Million TWD | 2301.83% |
| 2022 Q1 | -58.63 Million TWD | -99.45% |
| 2021 Q3 | -56.84 Million TWD | -450.99% |
| 2021 Q1 | 80 Million TWD | -12.57% |
| 2021 FY | -4.76 Million TWD | -101.9% |
| 2021 Q2 | 16.19 Million TWD | -79.76% |
| 2021 Q4 | -29.39 Million TWD | 48.28% |
| 2020 FY | 250.94 Million TWD | 669.71% |
| 2020 Q3 | 45.04 Million TWD | 96.06% |
| 2020 Q2 | 22.97 Million TWD | -74.87% |
| 2020 Q1 | 91.42 Million TWD | 120.86% |
| 2020 Q4 | 91.5 Million TWD | 103.16% |
| 2019 Q2 | -34.76 Million TWD | -156.79% |
| 2019 Q4 | 41.39 Million TWD | 2003.46% |
| 2019 Q3 | 1.96 Million TWD | 105.66% |
| 2019 FY | -44.04 Million TWD | 87.75% |
| 2019 Q1 | -13.53 Million TWD | 87.95% |
| 2018 FY | -359.54 Million TWD | -1714.27% |
| 2018 Q4 | -112.37 Million TWD | -16.22% |
| 2018 Q3 | -96.69 Million TWD | -84.85% |
| 2018 Q2 | -52.31 Million TWD | 46.71% |
| 2018 Q1 | -98.16 Million TWD | -84.29% |
| 2017 FY | 22.27 Million TWD | 110.72% |
| 2017 Q3 | 16.7 Million TWD | -63.44% |
| 2017 Q1 | 13.13 Million TWD | -33.11% |
| 2017 Q2 | 45.69 Million TWD | 248.05% |
| 2017 Q4 | -53.26 Million TWD | -418.81% |
| 2016 Q4 | 19.63 Million TWD | 140.16% |
| 2016 FY | -207.69 Million TWD | 57.94% |
| 2016 Q1 | -117.35 Million TWD | 27.5% |
| 2016 Q3 | -48.88 Million TWD | 19.98% |
| 2016 Q2 | -61.08 Million TWD | 47.95% |
| 2015 Q4 | -161.87 Million TWD | -39.18% |
| 2015 Q3 | -116.31 Million TWD | -18.7% |
| 2015 FY | -493.79 Million TWD | -38.79% |
| 2015 Q2 | -97.98 Million TWD | 16.69% |
| 2015 Q1 | -117.61 Million TWD | 28.11% |
| 2014 Q3 | -101.36 Million TWD | -81.81% |
| 2014 FY | -355.79 Million TWD | -55.57% |
| 2014 Q4 | -163.61 Million TWD | -61.42% |
| 2014 Q2 | -55.75 Million TWD | 23.31% |
| 2014 Q1 | -72.69 Million TWD | 8.32% |
| 2013 Q1 | -55.9 Million TWD | 46.77% |
| 2013 Q4 | -79.29 Million TWD | -110.92% |
| 2013 FY | -228.7 Million TWD | 49.5% |
| 2013 Q3 | -37.59 Million TWD | 32.76% |
| 2013 Q2 | -55.9 Million TWD | 0.0% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 FY | -452.83 Million TWD | -93.06% |
| 2012 Q4 | -105.03 Million TWD | 0.0% |
| 2012 Q3 | -105.03 Million TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 FY | -234.56 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 157.993% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 88.036% |
| Level Biotechnology Inc. | 62.9 Million TWD | 52.261% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 154.561% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 146.454% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 115.415% |
| GlycoNex Incorporation | -178.36 Million TWD | 116.837% |
| VBI | -6.6 Million TWD | 554.931% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 118.061% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | 381.127% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 178.67% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 117.868% |
| Visgeneer Inc. | -19.58 Million TWD | 253.3% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 104.398% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 95.201% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 58.522% |
| Neith Corporation | -40.03 Million TWD | 175.013% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 102.589% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | 596.61% |
| Enimmune corporation | -223.74 Million TWD | 113.422% |
| TaiRx, Inc. | -212.29 Million TWD | 114.146% |
| CHO Pharma, Inc. | -306.08 Million TWD | 109.811% |
| EirGenix Inc. | -915.2 Million TWD | 103.281% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 39.63% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 147.426% |
| Lin BioScience, Inc. | -687.19 Million TWD | 104.37% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 119.21% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | -31.757% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 140.977% |
| Lukas Biomedical Inc. | -47.35 Million TWD | 163.417% |
| RBC Bioscience Corporation | 6.43 Million TWD | -367.03% |
| BiOptic Inc. | 37.74 Million TWD | 20.444% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 104.365% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 180.802% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 148.798% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 89.073% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 132.602% |
| NaviFUS Corp. | -65.72 Million TWD | 145.688% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 134.091% |
| Sinew Pharma Inc. | -170.92 Million TWD | 117.57% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 144.059% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 77.017% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 112.615% |
| AP Biosciences Inc | -339.29 Million TWD | 108.851% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 105.35% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 151.82% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | -255.132% |
| Intech Biopharm Corporation | -337.98 Million TWD | 108.885% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 102.287% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 158.183% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 117.594% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 94.433% |
| TCI GENE Inc. | 11.67 Million TWD | -157.26% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 123.544% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 110.135% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 113.806% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | -196.739% |
| PharmaEngine, Inc. | 274.65 Million TWD | 89.066% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 78.037% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 102.87% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 123.958% |
| Acepodia, Inc. | -817.31 Million TWD | 103.674% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 106.148% |